title: Employment status in persons with and without HIV infection in Denmark: 1996-2011.
abstract: OBJECTIVE
  To estimate annual employment rates and disability retirement rates (DRRs) among HIV-infected individuals and population controls during the period 1996-2011.
  
  
  METHODS
  A population-based cohort study including all HIV-infected individuals born in Denmark and not reporting intravenous (i.v.) drug abuse as a route of HIV infection or diagnosed with hepatitis C infection (n = 2799) and 22,369 individually matched persons from the background population. Study inclusion was 1 January 1996 or HIV diagnosis, which ever came last.
  
  
  METHODS
  Data on employment status and disability pension were extracted from Danish national registries. Employment rate and DRR were estimated in each calendar year after study inclusion for the cohorts included before 1996 (pre-1996), 1996-1999 and 2000-2011.
  
  
  RESULTS
  Employment rate in the year of study inclusion increased from 54.8% [95% confidence interval (CI) 50.5-59.6] in the pre-1996 cohort to 74.6% (66.9-83.2) and 77.4% (72.8-82.2) in the 1996-1999 and 2000-2011 cohorts, respectively, compared with 85.9-87.2% in the comparison cohorts. Five years from study inclusion, employment rates were 56.1 (51.4-61.1), 66.2 (58.7-74.6) and 70.9% (65.0-77.3) in the pre-1996, 1996-1999 and 2000-2011 cohorts, respectively, compared with 82.5-85.6% in the comparison cohorts. Five years from study inclusion, DRRs were 32.3 (28.9-36.3) in the pre-1996 cohort and decreased to 17.8 (14.1-22.4) and 11.6% (9.4-14.4) in the 1996-1999 and 2000-2011 cohorts, respectively, compared with 5.1-7.2% in the comparison cohorts.
  
  
  CONCLUSIONS
  After the introduction of HAART, employment rates have increased profoundly among HIV-infected individuals, but have remained lower than in the background population. During the same period, DRRs decreased among HIV-infected individuals, but still remained higher than in the background population.
authors.affiliation: aDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet bDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre cDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus dDepartment of Infectious Diseases, Odense University Hospital, Odense eDepartment of Infectious Diseases, Aalborg University Hospital, Aalborg fDepartment of Internal Medicine, Roskilde Hospital, Roskilde, Denmark.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Legarth
authors.forename: Lars Haukali
authors.initials: LH
authors.lastname: Omland
authors.forename: Gitte
authors.initials: G
authors.lastname: Kronborg
authors.forename: Carsten S
authors.initials: CS
authors.lastname: Larsen
authors.forename: Court
authors.initials: C
authors.lastname: Pedersen
authors.forename: Gitte
authors.initials: G
authors.lastname: Pedersen
authors.forename: Ulrik Bak
authors.initials: UB
authors.lastname: Dragsted
authors.forename: Jan
authors.initials: J
authors.lastname: Gerstoft
authors.forename: Niels
authors.initials: N
authors.lastname: Obel
mesh_terms: D000293:Adolescent; D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D015331:Cohort Studies; D003718:Denmark; D004651:Employment / Q000706:statistics & numerical data*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents